V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160687 | 20061979 | 1.76 | 89.5 | Adjuvant (A) | 2016-08-06 | 2016-08-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101480247 |
| 20160689 | 20061980 | 1.68 | 76 | Palliative (P) | 2018-02-02 | 2018-02-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101231259 |
| 20160693 | 20061981 | 1.71 | 73.1 | Palliative (P) | null | 2018-12-10 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100705399 |
| 20160694 | 20061982 | 1.47 | 75.8 | Palliative (P) | 2016-02-20 | 2016-03-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100582738 |
| 20160699 | 20061983 | 1.53 | 62.6 | Neo-adjuvant (N) | 2019-12-11 | 2019-12-31 | ECX | 02 | N | ECX | 101613117 |
| 20160701 | 20061984 | 1.83 | 61.5 | Adjuvant (A) | 2019-05-23 | 2019-05-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100174371 |
| 20160704 | 20061985 | 1.7 | 78 | Palliative (P) | 2017-12-27 | 2018-01-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101387763 |
| 20160705 | 20061986 | 1.57 | 51 | Palliative (P) | 2017-07-26 | 2017-10-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100212707 |
| 20160706 | 20061987 | 1.77 | 106.6 | Neo-adjuvant (N) | 2017-05-16 | 2017-05-23 | ECX | N | N | ECX | 100642420 |
| 20160708 | 20061988 | 1.63 | 72 | Adjuvant (A) | 2018-12-18 | 2019-01-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100635695 |
| 20160709 | 20061989 | 1.76 | 70 | Palliative (P) | 2017-11-15 | 2017-12-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101226859 |
| 20160710 | 20061990 | 1.75 | 48.6 | Neo-adjuvant (N) | 2016-09-17 | 2016-09-17 | ECX | N | N | ECX | 100665287 |
| 20160711 | 20061991 | 1.67 | 62 | Neo-adjuvant (N) | 2019-11-28 | 2019-11-28 | ECX | 02 | N | ECX | 101442375 |
| 20160712 | 20061992 | 1.73 | 86.2 | Neo-adjuvant (N) | 2019-01-06 | 2019-01-06 | ECX | N | N | ECX | 100255332 |
| 20160714 | 20061993 | 1.63 | 75 | Adjuvant (A) | 2016-06-19 | 2016-06-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100704519 |
| 20160718 | 20061994 | 1.87 | 86.1 | Palliative (P) | 2016-03-21 | 2016-03-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101161781 |
| 20160721 | 20061995 | 1.7 | 68.5 | Adjuvant (A) | null | 2020-02-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101062713 |
| 20160722 | 20061996 | 1.73 | 78.6 | Curative (C) | 2016-02-22 | 2016-02-24 | ECX | 02 | N | ECX | 100701097 |
| 20160729 | 20061997 | 1.77 | 58.55 | Palliative (P) | 2018-02-15 | 2018-02-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101199897 |
| 20160730 | 20061998 | 1.71 | 93.4 | Neo-adjuvant (N) | 2016-03-01 | 2016-03-03 | ECX | 2 | N | ECX | 100994637 |
| 20160734 | 20061999 | 1.74 | 62.1 | Palliative (P) | 2018-10-22 | 2018-10-29 | ECX | N | N | ECX | 101151376 |
| 20160737 | 20062000 | 1.77 | 51.6 | Palliative (P) | 2018-06-20 | 2018-06-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100234070 |
| 20160738 | 20062001 | 1.74 | 71.6 | null | 2016-06-03 | 2016-06-21 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100979215 |
| 20160740 | 20062002 | 1.56 | 51.7 | Neo-adjuvant (N) | 2019-05-06 | 2019-05-12 | ECX | N | N | ECX | 101669666 |
| 20160742 | 20062003 | 1.78 | 97.4 | Palliative (P) | 2017-04-12 | 2017-04-23 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100037236 |
| 20160745 | 20062004 | 1.7 | 83.3 | Curative (C) | 2019-07-20 | 2019-07-24 | ECX | N | N | ECX | 100958523 |
| 20160746 | 20062005 | 1.78 | 53.3 | Adjuvant (A) | 2016-08-13 | 2016-09-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101106373 |
| 20160748 | 20062006 | 1.7 | 65.35 | Palliative (P) | 2018-12-13 | 2019-01-13 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101623603 |
| 20160749 | 20062007 | 1.73 | 71.7 | Adjuvant (A) | 2019-04-22 | 2019-05-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101772388 |
| 20160750 | 20062008 | 1.87 | 51.4 | Curative (C) | 2016-07-22 | 2016-08-07 | ECX | N | N | ECX | 100734581 |
| 20160752 | 20062009 | 1.72 | 77 | Palliative (P) | 2017-06-09 | 2017-06-09 | ECX | 02 | N | ECX | 100950450 |
| 20160754 | 20062010 | 1.67 | 71.7 | Neo-adjuvant (N) | 2019-07-27 | 2019-07-27 | ECX | N | N | ECX | 100421382 |
| 20160755 | 20062011 | 1.65 | 63.2 | Palliative (P) | 2016-06-01 | 2016-06-01 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100580146 |
| 20160756 | 20062012 | 1.77 | 81.8 | Adjuvant (A) | 2019-10-07 | 2019-10-29 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101856025 |
| 20160759 | 20062013 | 1.75 | 46.2 | Palliative (P) | 2018-01-07 | 2018-01-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101161669 |
| 20160760 | 20062014 | 1.87 | 108 | Adjuvant (A) | 2017-01-24 | 2017-02-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100957416 |
| 20160761 | 20062015 | 1.76 | 84 | Neo-adjuvant (N) | 2018-05-14 | 2018-05-17 | ECX | 2 | N | ECX | 101130379 |
| 20160762 | 20062016 | 1.76 | 70.2 | Neo-adjuvant (N) | 2017-04-03 | 2017-04-30 | ECX | N | null | ECX | 100886562 |
| 20160763 | 20062017 | 1.66 | 46.3 | Neo-adjuvant (N) | 2016-07-31 | 2016-09-09 | ECX | N | N | ECX | 100770176 |
| 20160764 | 20062018 | 1.63 | 77.6 | Palliative (P) | 2017-12-29 | 2018-01-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100438364 |
| 20160766 | 20062019 | 1.73 | 72 | Palliative (P) | 2019-09-07 | 2019-09-09 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100355546 |
| 20160767 | 20062020 | 1.78 | 86 | Palliative (P) | 2018-02-06 | 2018-03-08 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101555427 |
| 20160768 | 20062021 | 1.64 | 56.2 | Palliative (P) | null | 2018-02-07 | ECX | null | N | ECX | 101007691 |
| 20160770 | 20062022 | 1.5 | 64.2 | Adjuvant (A) | 2018-09-13 | 2018-09-13 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100025652 |
| 20160773 | 20062023 | 1.73 | 60 | Neo-adjuvant (N) | 2016-12-18 | 2016-12-30 | ECX | N | N | ECX | 101476059 |
| 20160776 | 20062024 | 1.59 | 80.5 | Palliative (P) | 2020-04-27 | 2020-04-30 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101218380 |
| 20160781 | 20062025 | 1.74 | 66.6 | null | null | 2019-10-01 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100013137 |
| 20160782 | 20062026 | 1.6 | 57.4 | Neo-adjuvant (N) | 2016-08-14 | 2016-08-21 | ECX | 2 | N | ECX | 101432544 |
| 20160784 | 20062027 | 1.79 | 64.4 | Neo-adjuvant (N) | 2016-11-09 | 2016-11-27 | ECX | N | N | ECX | 100423484 |
| 20160786 | 20062028 | 1.48 | 54.5 | null | 2019-07-08 | 2019-07-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100557579 |